Trademark: 87641241
Status Date
Monday, March 28, 2022
Filing Date
Wednesday, October 11, 2017
Published for Opposition
Tuesday, December 25, 2018
Abandoned Date
Monday, March 28, 2022
5 Pharmaceutical preparations for the prevention and treatment of alzheimer's disease; pharmaceutical preparations for the prevention and treatment of depression; pharmaceutical preparations for the prevention and treatment of psychological disorders; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of osteoporosis; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; pharmaceutical preparations for the prevention and treatment of aids-related disorders; pharmaceutical preparations that support, encourage and promote bone strength; pharmaceutical preparations that support, encourage and promote bone health; pharmaceutical preparations used in the treatment of bone disorders and bone diseases; pharmaceutical preparations, namely, injectable contraceptives; pharmaceutical preparations, namely, contraceptive preparations; pharmaceutical preparations, namely, fertility enhancement preparations; pharmaceutical preparations, namely, hormone replacement therapy preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations, namely, pharmaceutical agents affecting the central nervous system; pharmaceutical preparations, namely, pharmaceutical agents affecting circulatory systems; pharmaceutical preparations, namely, pharmaceutical agents affecting sensory organs; pharmaceutical preparations, namely, pharmaceutical agents affecting urogenital organs; pharmaceutical preparations, namely, pharmaceutical agents affecting peripheral nervous system
Mar 28, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 28, 2022
Abandonment - No Use Statement Filed
Aug 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 9, 2021
Sou Extension 5 Granted
Aug 4, 2021
Sou Extension 5 Filed
Aug 9, 2021
Case Assigned To Intent To Use Paralegal
Aug 4, 2021
Sou Teas Extension Received
Feb 13, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 11, 2021
Sou Extension 4 Granted
Feb 11, 2021
Sou Extension 4 Filed
Feb 11, 2021
Sou Teas Extension Received
Aug 15, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 13, 2020
Sou Extension 3 Granted
Aug 13, 2020
Sou Extension 3 Filed
Aug 13, 2020
Sou Teas Extension Received
Feb 29, 2020
Notice Of Approval Of Extension Request E-Mailed
Feb 19, 2020
Sou Extension 2 Granted
Feb 19, 2020
Sou Extension 2 Filed
Feb 19, 2020
Sou Teas Extension Received
Aug 16, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 14, 2019
Sou Extension 1 Granted
Aug 14, 2019
Sou Extension 1 Filed
Aug 14, 2019
Sou Teas Extension Received
Aug 13, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 13, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 19, 2019
Noa E-Mailed - Sou Required From Applicant
Dec 25, 2018
Official Gazette Publication Confirmation E-Mailed
Dec 25, 2018
Published For Opposition
Dec 5, 2018
Notification Of Notice Of Publication E-Mailed
Nov 16, 2018
Approved For Pub - Principal Register
Nov 13, 2018
Teas/Email Correspondence Entered
Nov 13, 2018
Correspondence Received In Law Office
Nov 6, 2018
Assigned To Lie
Oct 26, 2018
Teas Response To Suspension Inquiry Received
Aug 7, 2018
Notification Of Letter Of Suspension E-Mailed
Aug 7, 2018
Letter Of Suspension E-Mailed
Aug 7, 2018
Suspension Letter Written
Jul 12, 2018
Teas/Email Correspondence Entered
Jul 11, 2018
Correspondence Received In Law Office
Jul 11, 2018
Teas Response To Office Action Received
Jan 16, 2018
Notification Of Non-Final Action E-Mailed
Jan 16, 2018
Non-Final Action E-Mailed
Jan 16, 2018
Non-Final Action Written
Jan 10, 2018
Assigned To Examiner
Oct 18, 2017
New Application Office Supplied Data Entered
Oct 14, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
